Antibodies with enhanced ability to immunomodulate cell functions

Details for Australian Patent Application No. 2004226167 (hide)

International Classifications

Event Publications

20 October 2005 PCT application entered the National Phase

PCT publication WO2004/087757 Priority application(s): WO2004/087757

15 January 2009 Assignment before Grant

Institut National de La Sante et de La Recherche Medicale (INSERM); Laboratoire Francais Du Fractionnement et des Biotechnologies The application has been assigned to Institut National de La Sante et de La Recherche Medicale (INSERM); LFB Biotechnologies

3 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.